mavoglurant (STP7) / Novartis, STALICLA 
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mavoglurant (STP7) / STALICLA
Parkinson disease-1: AFQ056 in Phase III development for the treatment of Parkinson's disease levodopa-induced dyskinesia.

Ongoing
3
0
RestOfWorld
mavoglurant (AFQ056)
Novartis
Parkinson's Disease
 
 
STA-P7-C001, NCT06273540: Phase1, STP7 Cocaine Drug-Drug Interaction Study

Recruiting
1
20
US
STP7 (mavoglurant) or Placebo, Cocaine, Saline infusion
Stalicla SA, National Institute on Drug Abuse (NIDA)
Cocaine Use Disorder
09/24
09/24

Download Options